Inhibikase Therapeutics Announces Inducement Grants

Inhibikase Therapeutics announced the grant of non-qualified stock options to purchase up to 128,000 shares of its common stock to two newly-hired employees, in accordance with Nasdaq Listing Rule 5635(c)(4).